Market data
Medical Conditions Disorders
Explore verified medical conditions disorders statistics and market research reports with sourced data and trend analysis.
Latest update:
Elif Demirci
Kyphosis Statistics
Kyphosis rarely travels alone, with 70 to 90 percent of idiopathic scoliosis cohorts showing abnormal sagittal alignment alongside kyphotic patterns. From 3.3 percent thoracic hyperkyphosis in U.S. adults and 12.7 percent in those 65 and older to surgery outcomes and imaging practice shifts, the page connects prevalence, fracture risk, and real-world care choices so you can see why kyphosis planning is not just posture, it is prognosis.
Sepsis Statistics
With sepsis mortality estimated at 48.9% globally in 2017 yet trials show early goal directed care can cut 28 day mortality by an absolute 16%, this page pinpoints exactly where time and practice make the biggest difference. You will also see how faster antibiotics, better source control, and modern tools like EHR alerts and procalcitonin guidance translate into measurable outcomes alongside the major U.S. cost toll, where sepsis adds about $24.3 billion in annual economic burden.
Celiac Statistics
From a roughly 6 to 10% osteoporosis hit at diagnosis to a 4 year median diagnostic delay, these celiac disease statistics put the biggest clinical gaps and risks side by side. You also get current, diet linked contrasts such as 31% reporting monthly accidental gluten exposure and around 19% still showing persistent tTG or EMA positivity after 12 months, alongside the lifelong economic and health tradeoffs that follow.
Hsv 2 Statistics
Get the reality check on HSV-2 testing and transmission, where PCR of lesion swabs is 95 to 100% sensitive and specificity for type-specific IgG runs 96 to 100% after 3 months, yet early infection can still slip past serology with false negatives in up to 30% within 12 weeks. You will also see why asymptomatic shedding accounts for about 70% of transmissions and how outcomes shift when you switch from culture and unreliable IgM to NAAT and Western blot confirmation.
Sciatica Statistics
Sciatica shows up in only 1% to 2% of primary care visits yet it can quietly drag quality of life down and still leave 23% of people with persistent symptoms one year after an acute episode. This page connects the MRI and test realities with what patients and payers actually face, including that low back pain drives 8.7% of global YLDs and repeat surgery after discectomy is often reported at 5% to 15%.
Ehlers Danlos Syndrome Statistics
From Beighton score cutoffs and hEDS major criteria to lab level confirmation like COL3A1 sequencing for 95% of vEDS and electron microscopy “cauliflower” collagen in 90% of cEDS, this page turns EDS diagnosis into a map you can actually use. It also tracks how often key comorbidities and surveillance matter, including a 98% molecular confirmation rate in vEDS families and POTS appearing in about 80% of suspected cases, so you see where symptoms, tests, and risk truly converge.
Anorexia Death Statistics
Females aged 15 to 19 face the highest anorexia mortality rate in the US at 2.5 per 100,000, yet males make up 10 to 25% of deaths with a higher SMR of 9.0 versus 6.5 in females. From autism, perfectionism, and BMI below 12 to pandemic driven changes and major international differences, Anorexia Death maps the sharp risk shifts that determine who survives and who does not.
Female Infertility Statistics
Nearly 1 in 5 women will face infertility, and female factors account for about 37% of cases in large reviews, yet age changes the odds fast with fertility falling after 35. This page connects that reality to real clinic activity and care thresholds, including 387,013 embryo transfers in the US reported for 2019 and key NICE guidance on when to investigate and how anovulation and endometriosis are managed.
Polycystic Ovary Syndrome Statistics
Around 116 million women worldwide live with PCOS and the page connects the diagnostic rules that set Rotterdam and NIH criteria apart, from ultrasound follicle thresholds to biochemical androgen cutoffs. It also spotlights the metabolic and endocrine signals that often go unnoticed, including impaired glucose tolerance in 30 to 40 percent, insulin resistance flagged by HOMA IR above 2.5, and which lab and imaging checks like prolactin, TSH, and pelvic ultrasound help rule out lookalikes.
Epilepsy Death Statistics
People with epilepsy die about 15 years prematurely on average, with mortality often rising sharply in the young and in disadvantaged settings, including SUDEP peaking in adolescents and young adults where the risk is highest at 2.3 per 1,000 in ages 20 to 44 and 24x higher than the general population. This page connects global figures and preventable drivers such as uncontrolled seizures, subtherapeutic AED use, and lack of monitoring to show who is most at risk and what can shift those outcomes.
Periodontal Disease Statistics
Periodontal disease is not just a gum problem since it multiplies tooth loss risk, raises stroke and cardiovascular mortality, and can worsen diabetes, pregnancy outcomes, pneumonia risk, and even dementia. See why the page also highlights what works, including treatment lowering HbA1c by 0.4% in diabetics in 3 months and improving long term tooth survival, alongside current prevalence figures such as 47.2% of US adults aged 30 and older having some form of periodontal disease.
Copd Mortality Statistics
COPD is still a leading killer, with 3.45 million deaths worldwide in 2021 and rates highest in older age groups, so the page highlights where the burden concentrates and why it persists. You will see sharp country contrasts across Asia and the US, plus the key drivers that keep mortality high such as smoking, PM2.5 air pollution, and indoor biomass fuels, even as some places show declines.
Preterm Birth Statistics
Before 32 weeks, infection and inflammation drive 40% of preterm births while spontaneous preterm labor accounts for 45 to 50%, and PPROM contributes another 30%. This page connects those timing and cause patterns to real outcomes and prevention options, from <28 weeks chorioamnionitis rates to how progesterone withdrawal triggers 50% of spontaneous labor.
Stage 4 Colon Cancer Survival Statistics
Stage 4 colon cancer survival can swing dramatically from trial to trial, with modern first line therapy pushing median overall survival to about 33.1 months in FIRE 3 and 31.2 months in CALGB SWOG 80405, while older second and third line options like regorafenib and TAS 102 sit closer to 6.4 and 7.1 months. You will also see how biology and inequality reshape outcomes, including a 5 year distant stage survival of 14.9 percent on SEER data and a striking 11.2 percent 5 year rate for African American patients versus 16.4 percent for whites.
Aed Statistics
Find out why AEDs are still missing where they matter most even though public availability already reaches 1.2 million devices worldwide, with only 11% of US shopping malls getting AEDs despite constant crowds. From survival gains tied to shock delivery within 3 minutes to the gap between schools at 62% coverage and homes under 1%, these 2025 based contrasts explain exactly what changes outcomes fastest.
Pancreatic Cancer Statistics
With 2023 US expectations of about 64,050 new pancreatic cancer cases, this page connects key diagnostic accuracy to what it means for real outcomes, from CA19-9 and EUS-FNA to CT, MRI, and PET/CT staging. You will also see why most cancers are found too late, including the 70 to 80 percent diagnosed at stage IV, and how survival, resectability signals, and emerging molecular testing like cfDNA KRAS help explain the gap between detection and cure.
Childbirth Complications Statistics
From stillbirth at 2.3% in the UK to clinically significant postpartum hemorrhage risk affecting an estimated 2.7% of pregnancies, these statistics trace how different emergencies add up and which ones escalate fastest. You will also see how 5.8 million women face potentially life threatening obstetric complications each year globally, alongside care and prevention gaps that help explain why preventable deaths remain stubbornly high.
Breast Cancer Treatment Statistics
From pCR swings like 22.5% with dose-dense AC T followed by paclitaxel to 61.1% with neoadjuvant TCHP in KRISTINE, this page shows exactly how modern breast cancer regimens change outcomes, and where the biggest tradeoffs land. You will also see how maintenance and residual disease strategies tilt the odds, including adjuvant olaparib after chemo in high risk early disease improving DFS to 0.58 versus control in OlympiA, and adjuvant capecitabine raising 5 year DFS to 69.8% versus 56% in residual TNBC from CREATE-X.
Prostate Cancer Statistics
Prostate cancer still accounts for 7.3% of all cancer cases worldwide, yet the right testing and treatment path can shift outcomes dramatically, from about a 20% lower mortality with PSA screening in the ERSPC trial to MRI and PSMA strategies that better pinpoint clinically significant disease. This page brings these key incidence, screening, biopsy, and therapy statistics together so you can see where evidence lines up for men with localized low risk through metastatic prostate cancer.
Cardiomyopathy Statistics
With 1 in 625 people in the UK living with hypertrophic cardiomyopathy, and amyloid cardiomyopathy tied to about a 34% 5 year survival in older cohorts, the stakes look very different depending on the subtype. The page also connects guideline changing thresholds and trial grade treatment effects, from HCM accounting for about 35% of sudden cardiac deaths in ages 1 to 35 to SGLT2 inhibitors now class I for HFrEF, so you can see exactly what current evidence implies for risk and care.